The neuronal K+Cl− co-transporter 2 (Slc12a5) modulates insulin secretion

Medical Sciences Medical Physiology Biochemistry Gene Mice Endocrinology Diabetes mellitus KATP Channels Insulin-Secreting Cells Insulin Secretion Endocrine system Medicine and Health Sciences Insulin Internal medicine Neurons 0303 health sciences Symporters Q R Life Sciences Medical Cell Biology Pyridazines Chemistry Enteroendocrine cell K Cl- Cotransporters Glibenclamide Medicine Islet Cell biology Science Pancreatic islets Molecular Mechanisms of Aquaporins in Physiology and Disease Transporter Article Cell Line 03 medical and health sciences Biochemistry, Genetics and Molecular Biology Sulfonylurea receptor Health Sciences Animals Humans Amino Acid Sequence Pancreatic Islet Dysfunction and Regeneration Molecular Biology Biology Secretion Base Sequence Endocrine and Autonomic Systems Neurosciences Neuron Glucagon Hormone Intracellular Alternative Splicing Thiazoles Glucose Medical Neurobiology Calcium Surgery Neuroendocrine Regulation of Appetite and Body Weight Physiological Processes Neuroscience
DOI: 10.1038/s41598-017-01814-0 Publication Date: 2017-05-04T17:43:54Z
ABSTRACT
AbstractIntracellular chloride concentration ([Cl−]i) in pancreatic β-cells is kept above electrochemical equilibrium due to the predominant functional presence of Cl− loaders such as the Na+K+2Cl− co-transporter 1 (Slc12a2) over Cl−extruders of unidentified nature. Using molecular cloning, RT-PCR, Western blotting, immunolocalization and in vitro functional assays, we establish that the “neuron-specific” K+Cl− co-transporter 2 (KCC2, Slc12a5) is expressed in several endocrine cells of the pancreatic islet, including glucagon secreting α-cells, but particularly in insulin-secreting β-cells, where we provide evidence for its role in the insulin secretory response. Three KCC2 splice variants were identified: the formerly described KCC2a and KCC2b along with a novel one lacking exon 25 (KCC2a-S25). This new variant is undetectable in brain or spinal cord, the only and most abundant known sources of KCC2. Inhibition of KCC2 activity in clonal MIN6 β-cells increases basal and glucose-stimulated insulin secretion and Ca2+ uptake in the presence of glibenclamide, an inhibitor of the ATP-dependent potassium (KATP)-channels, thus suggesting a possible mechanism underlying KCC2-dependent insulin release. We propose that the long-time considered “neuron-specific” KCC2 co-transporter is expressed in pancreatic islet β-cells where it modulates Ca2+-dependent insulin secretion.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (87)
CITATIONS (30)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....